|
|
|
|
|
|
|
SIZE:
|
|
|
|
GENERIC NAME:
|
|
|
|
MANUFACTURER:
|
|
|
|
UNIT:
|
|
|
|
ADMINISTRATION ROUTE:
|
|
|
|
FDA PREGNANCY GROUP:
|
|
C
|
|
INDICATIONS:
|
|
Bronchitis, chronic, acute exacerbation |
|
Conjunctivitis, infectious |
|
Gonorrhea |
|
Infection, cervix |
|
Infection, ear, external |
|
Infection, ear, middle |
|
Infection, lower respiratory tract |
|
Infection, skin and skin structure |
|
Infection, urinary tract |
|
Pneumonia, community- acquired |
|
Prostatitis |
|
Ulcer, corneal |
|
Urethritis |
| |
|
|
SIDE EFFECTS:
|
|
Central nervous system (CNS) stimulation |
|
hypersensitivity reactions |
|
phototoxicity |
|
pseudomembranous colitis |
|
tendinitis or tendon rupture |
|
CNS effects |
|
gastrointestinal effects |
|
taste perversion |
|
vaginal candidiasis |
|
Abdominal or stomach cramps and pain, severe |
|
abdominal tenderness |
|
diarrhea, watery and severe, which may also be bloody |
|
fever |
|
|
ABSOLUTE
CONTRAINDICATIONS :
|
|
|
|
RELATIVE
CONTRAINDICATIONS : |
|
>> Diabetes mellitus |
|
>> Renal function impairment |
|
CNS disorders, including cerebral arteriosclerosis or epilepsy |
|
|
ADULT DOSE:
|
|
Bronchitis, bacterial exacerbations, treatment-
Oral, 500 mg every twenty-four hours for seven days.
Pneumonia, community-acquired, treatment-
Oral, 500 mg every twenty-four hours for seven to fourteen days.
Pyelonephritis, treatment-
Oral, 250 mg every twenty-four hours for ten days.
Sinusitis, treatment-
Oral, 500 mg every twenty-four hours for ten to fourteen days.
Skin and soft tissue infections, treatment-
Oral, 500 mg every twenty-four hours for seven to ten days.
Urinary tract infections, bacterial, complicated, treatment-
Oral, 250 mg every twenty-four hours for ten days. |
|
MAXIMUM ADULT DOSE:
|
|
|
|
PEDIATRIC DOSE:
|
|
Safety and efficacy have not been established .
|
|
MAXIMUM PEDIATRIC
DOSE:
|
|
|
|
ELDERLY DOSE:
|
|
|
|
|
|
|
|